SMMT
NASDAQ · Biotechnology
Summit Therapeutics Inc
$14.19
-1.98 (-12.24%)
Performance
1D
—
1W
-11.48%
1M
-20.95%
3M
-4.57%
6M
-23.95%
1Y
-23.09%
YTD
-19.01%
Open$16.10
Previous Close$16.17
Day High$16.12
Day Low$14.17
52W High$29.23
52W Low$12.07
Volume—
Avg Volume4.67M
Market Cap12.66B
P/E Ratio—
EPS$-1.12
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$16.21
Below
SMA 200
$16.16
Below
RSI (14)
54.8
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
24 analysts
Price Target
+1,281.8% upside
Current
$14.19
$14.19
Target
$196.08
$196.08
$141.53
$196.08 avg
$244.39
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.10B | 1.08B | 883.89M |
| Net Income | 169.72M | 168.86M | 142.65M |
| Profit Margin | 15.4% | 15.6% | 16.1% |
| EBITDA | 286.46M | 306.19M | 235.37M |
| Free Cash Flow | 170.10M | 157.58M | 108.43M |
| Rev Growth | -3.6% | +10.5% | -9.8% |
| Debt/Equity | 1.16 | 1.05 | 1.18 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.34 | +1.08% | 81.4 | 513.86B |
| AMGN | Amgen Inc | $461.10 | +0.18% | 28.5 | 249.09B |
| GILD | Gilead Sciences Inc | $168.18 | +0.36% | — | 212.04B |
| VRTX | Vertex Pharmaceuticals Inc | $546.92 | +0.81% | 30.6 | 134.77B |
| REGN | Regeneron Pharmaceuticals | $908.12 | +0.58% | 19.5 | 84.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $157.53 | +0.56% | 28.8 | 23.28B |